These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 15033529)

  • 1. Transgene stability for three replication-competent murine leukemia virus vectors.
    Duch M; Carrasco ML; Jespersen T; Hansen BD; Pedersen FS
    Gene; 2004 Mar; 329():61-9. PubMed ID: 15033529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of viral strain, transgene position, and target cell type on replication kinetics, genomic stability, and transgene expression of replication-competent murine leukemia virus-based vectors.
    Paar M; Schwab S; Rosenfellner D; Salmons B; Günzburg WH; Renner M; Portsmouth D
    J Virol; 2007 Jul; 81(13):6973-83. PubMed ID: 17442710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Murine leukemia virus (MLV) replication monitored with fluorescent proteins.
    Sliva K; Erlwein O; Bittner A; Schnierle BS
    Virol J; 2004 Dec; 1():14. PubMed ID: 15610559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cell-specific expression from Mo-MLV retroviral vectors containing a CD4 mini-promoter/enhancer.
    Zhao-Emonet JC; Marodon G; Pioche-Durieu C; Cosset FL; Klatzmann D
    J Gene Med; 2000; 2(6):416-25. PubMed ID: 11199262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction of retroviral vectors with enhanced efficiency of transgene expression.
    Hahm SH; Yi Y; Lee DK; Noh MJ; Yun L; Hwang S; Lee KH
    J Virol Methods; 2004 Nov; 121(2):127-36. PubMed ID: 15381349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of heterologous genes from an IRES translational cassette in replication competent murine leukemia virus vectors.
    Jespersen T; Duch M; Carrasco ML; Warming S; Pedersen FS
    Gene; 1999 Nov; 239(2):227-35. PubMed ID: 10548723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of posttranscriptional regulatory elements on transgene expression and virus production in the context of retrovirus vectors.
    Hlavaty J; Schittmayer M; Stracke A; Jandl G; Knapp E; Felber BK; Salmons B; Günzburg WH; Renner M
    Virology; 2005 Oct; 341(1):1-11. PubMed ID: 16054668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Site-specific integration of functional transgenes into the human genome by adeno/AAV hybrid vectors.
    Recchia A; Perani L; Sartori D; Olgiati C; Mavilio F
    Mol Ther; 2004 Oct; 10(4):660-70. PubMed ID: 15451450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient gene transfer into spleen cells of newborn mice by a replication-competent retroviral vector.
    Bachrach E; Pelegrin M; Piechaczyk M; Pedersen FS; Duch M
    Virology; 2002 Feb; 293(2):328-34. PubMed ID: 11886253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Replicating foamy virus-based vectors directing high level expression of foreign genes.
    Schmidt M; Rethwilm A
    Virology; 1995 Jun; 210(1):167-78. PubMed ID: 7793069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VSV-G pseudotyped, MuLV-based, semi-replication-competent retrovirus for cancer treatment.
    Qiao J; Moreno J; Sanchez-Perez L; Kottke T; Thompson J; Caruso M; Diaz RM; Vile R
    Gene Ther; 2006 Oct; 13(20):1457-70. PubMed ID: 16724095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction of avian adenovirus CELO recombinants in cosmids.
    François A; Eterradossi N; Delmas B; Payet V; Langlois P
    J Virol; 2001 Jun; 75(11):5288-301. PubMed ID: 11333910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization of regulated LTR-mediated expression.
    Lorens JB; Jang Y; Rossi AB; Payan DG; Bogenberger JM
    Virology; 2000 Jun; 272(1):7-15. PubMed ID: 10873744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of murine leukemia virus-based retroviral vectors with a minimum possibility of cis-activation.
    Jang J; Lee JT; Lee K; Kim S; Kim JY; Yoon K; Kim S
    Gene Ther; 2011 Mar; 18(3):240-9. PubMed ID: 20944681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional inactivation of amphotropic murine leukemia virus replication in human cells.
    Ploss M; Berdel B; Heber R; Reuss FU
    J Med Virol; 2003 Feb; 69(2):267-72. PubMed ID: 12683417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High efficiency retroviral vectors that contain no viral coding sequences.
    Yu SS; Kim JM; Kim S
    Gene Ther; 2000 May; 7(9):797-804. PubMed ID: 10822307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody-mediated targeting of replication-competent retroviral vectors.
    Tai CK; Logg CR; Park JM; Anderson WF; Press MF; Kasahara N
    Hum Gene Ther; 2003 May; 14(8):789-802. PubMed ID: 12804141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Replicating retroviral vectors mediating continuous production and secretion of therapeutic gene products from cancer cells.
    Finger C; Sun Y; Sanz L; Alvarez-Vallina L; Buchholz CJ; Cichutek K
    Cancer Gene Ther; 2005 May; 12(5):464-74. PubMed ID: 15692609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A uniquely stable replication-competent retrovirus vector achieves efficient gene delivery in vitro and in solid tumors.
    Logg CR; Tai CK; Logg A; Anderson WF; Kasahara N
    Hum Gene Ther; 2001 May; 12(8):921-32. PubMed ID: 11387057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors affecting the performance of different long terminal repeats in the retroviral vector.
    Kim S; Lee K; Kim MD; Kang S; Joo CW; Kim JM; Kim SH; Yu SS; Kim S
    Biochem Biophys Res Commun; 2006 May; 343(4):1017-22. PubMed ID: 16574062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.